Candia, Teresita R.

HRN: 27-10-75  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/08/2026
CLINDAMYCIN 150MG/ML, 4ML (AMP)
01/08/2026
01/14/2026
IV
600mg
Q6
Nonhealing Wound
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Skin & Soft Tissue    Compliance to guidelines: Compliant To Guidelines